Results 171 to 180 of about 5,702,542 (372)

Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications

open access: yesBlood Cancer Journal, 2021
Hiroto Ohguchi   +2 more
doaj   +1 more source

A Bayesian joint model of multiple nonlinear longitudinal and competing risks outcomes for dynamic prediction in multiple myeloma: joint estimation and corrected two-stage approaches [PDF]

open access: yesarXiv
Predicting cancer-associated clinical events is challenging in oncology. In Multiple Myeloma (MM), a cancer of plasma cells, disease progression is determined by changes in biomarkers, such as serum concentration of the paraprotein secreted by plasma cells (M-protein). Therefore, the time-dependent behaviour of M-protein and the transition across lines
arxiv  

Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential

open access: yesChemBioEng Reviews, EarlyView.
This review explores key bioactives in brown algae and their antioxidant, anti‐inflammatory, anticancer, and antimicrobial properties. Covering studies from 2014 to 2024, it highlights their relevance in pharmaceuticals, nutraceuticals, cosmetics, and foods, while addressing challenges and future directions to unlock their full potential.
Irvin Fonseca‐Barahona   +2 more
wiley   +1 more source

I-OPen: inferior outcomes of penta-refractory compared to penta-exposed multiple myeloma patients

open access: yesBlood Cancer Journal, 2022
Sarvarinder K. Gill   +9 more
doaj   +1 more source

Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma

open access: yesCell Reports, 2018
Summary: The relationship between promoter proximal transcription factor-associated gene expression and super-enhancer-driven transcriptional programs are not well defined.
Mariateresa Fulciniti   +12 more
doaj  

Multiple Myeloma [PDF]

open access: bronze, 1935
Tom A. Outland, Joseph B. Cady
openalex   +1 more source

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

open access: yesThe Lancet Oncology, 2014
S. Rajkumar   +33 more
semanticscholar   +1 more source

Boron‐Based Functionalities Enhance, the Potency of 2,5‐Dimethylfuran‐Based IDO1 Inhibitors

open access: yesChemBioChem, EarlyView.
‐, , , ‐ , Indoleamine‐2,3‐dioxygenase‐1 (IDO1), a key immunoregulatory enzyme, is inhibited by novel boron derivatives (closo‐1,2‐ and 1,7‐carborane, boronic acids and esters, and benzoxaboroles) of 2,5‐dimethylfuran, each displaying low μM affinity for the human recombinant enzyme.
Thomas J. C. Carraro   +4 more
wiley   +1 more source

Free‐breathing accelerated whole‐body MRI using an automated workflow: Comparison with conventional breath‐hold sequences

open access: yesNMR in Biomedicine, Volume 36, Issue 2, February 2023., 2023
Free‐breathing whole‐body MRI in tandem with an automated user interface yielded similar diagnostic accuracy at equivalent image quality and shorter acquisition times compared with breath‐hold MR sequences. Scores for patient satisfaction were significantly better for free‐breathing compared with breath‐hold examinations, including significant ...
Vitali Koch   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy